Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Flow cytometry is extensively used for the immune-profiling of leukocytes in tissue during homeostasis and inflammation. The multiparametric power of using fluorescently conjugated antibodies for specific surface and activation markers provides a comprehensive profile of immune cells. This chapter describes the identification and characterization of myeloid populations using flow cytometric analysis in an acute model of resolving inflammation. This model allows the examination of heterogenic populations across different systemic and tissue locations. We describe tissue processing, antibody staining, and analysis, which include a newly described viSNE tool to generate two-dimensional clustering within myeloid populations. We also reference the use of transgenic reporter mice on specific myeloid cells that provides enhanced specificity and profiling when defining myeloid heterogeneity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/978-1-4939-7680-5_7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Leveraging Machine Learning for Rapid and Accurate Diagnosis of Acute Leukemia.
Int J Lab Hematol
September 2025
Dr Lal Pathlabs Ltd, National Reference Laboratory, New Delhi, India.
Context: Early detection of acute leukemia (AL) is crucial for timely intervention and improved outcomes. Machine learning (ML) models provide a promising approach for early screening and rapid diagnosis of AL, minimizing delays in referral.
Objectives: To assess the utility of leukocyte cell population data (CPD) through ML models for detecting AL.
The role of clonal hematopoiesis of indeterminate potential in non-hematological malignancies of various origins.
Biochim Biophys Acta Rev Cancer
September 2025
Department of Hematology, Navy Medical Center of PLA, Naval Medical University, Shanghai 200052, China,. Electronic address:
Clonal hematopoiesis of indeterminate potential (CHIP) bridges hematopoietic clonality and solid tumorigenesis, unveiling a systemic dimension of somatic mutagenesis in cancer biology. Generally, population studies demonstrate CHIP carriers face elevated risks of cancer and poorer survival outcomes. This review consolidates current knowledge on the role of CHIP as potential biomarkers in the prediction/early detection/prognosis evaluation of various non-hematological cancers.
View Article and Find Full Text PDFEpidural blood patch for cerebrospinal fluid leak-induced subdural hematoma in a pediatric patient: illustrative case.
J Neurosurg Case Lessons
September 2025
Division of Pediatric Neurosurgery, Children's Hospital Los Angeles, Los Angeles, California.
Background: Intracranial hypotension (IH) is a secondary headache syndrome that can result from spontaneous or iatrogenic CSF leaks. Subdural hematomas (SDHs) are a particularly dangerous sequela of IH. Although epidural blood patch (EBP) is a recognized treatment for IH, its use in pediatric patients with SDH as a solitary intervention has not been reported.
View Article and Find Full Text PDFPublished Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric Patients.
Target Oncol
September 2025
Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Background: Population pharmacokinetic models can potentially provide suggestions for an initial dose and the magnitude of dose adjustment during therapeutic drug monitoring procedures of imatinib. Several population pharmacokinetic models for imatinib have been developed over the last two decades. However, their predictive performance is still unknown when extrapolated to different populations, especially children.
View Article and Find Full Text PDFSeeing something new or with new eyes?
Br J Haematol
September 2025
Nuffield Department of Population Health, University of Oxford, Oxford, UK.
When a new phenomenon is reported, despite many previous reports on larger cohorts of patients, one naturally asks why the finding is novel. Is this a new phenomenon, or merely identified because one is looking carefully for it for the first time? This commentary explores possible reasons for the novel finding of essential thrombocytopenia emerging in a cohort of Nucleophosmin 1 (NPM1)-mutated acute myeloid leukaemia (AML) patients. Commentary on: Bertoli et al.
View Article and Find Full Text PDF